Cell-matrix interactions of normal and transformed human keratinocytes in vitro are modulated by the synthetic phospholipid analogue hexadecylphosphocholine

British Journal of Dermatology

Volumn 135, Issue 5, 1996, Pages 696-703

  Schon M ^b,c   Schon M P ^b,c   Geilen, C C ^b   Hoffmann, M ^b   Hakyi, N ^b   Orfanos, C E ^b   Reutter, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; LAMININ;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

EID: 0029857584     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb03876.x     Document Type: Article

References (39)

1. Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980; 19: 1033-42.
2. Dover R, Watt FM. Measurement of the rate of epidermal terminal differentiation: Expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J Invest Dermatol 1987; 89: 349-52.
3. Doran TI, Vidrich A, Sun T-T. Intrinsic and extrinsic regulation of the differentiation of skin, corneal and esophageal epithelial cells. Cell 1980; 22: 17-25.
4. Bowden PE, Stark H-J, Breitkreutz D, Fusenig NE. Expression and modification of keratins during terminal differentiation of mammalian epidermis. In: Current Topics in Developmental Biology. Moscona AA, Sawyer R (eds), Vol. 22. Orlando, FL: Academic Press, 1987; pp. 35-68.
5. Read J, Watt FM. A model for in vitro studies of epidermal homeostasis: proliferation and involucrin synthesis by cultured human keratinocytes during recovery after stripping off the subrabasal layers. J Invest Dermatol 1988; 90: 739-43.
6. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993; 73: 713-24.
7. Fusenig NE, Breitkreutz D, Dzarlieva RT et al. Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 1983; 81 (Suppl.): 168-75.
8. Fusenig NE, Boukamp P, Breitkreutz D et al. Oncogenes and malignant transformation of human keratinocytes. In: Anticarcinogenesis and Radiation Protection. (Cerutti PA, Nygaard OF, Simic MG, eds). New York: Plenum Press, 1987; 227-31.
9. Rheinwald JG, Bechett MA. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 1980; 22: 629-32.
10. Klein CE, Cordon-Cardo C, Soehnchen R et al. Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. J Invest Dermatol 1987; 89: 500-6.
11. 14C]-choline. J Labelled Comp Radiopharm 1992; 31: 1071-6.
12. Detmar M, Geilen CC, Wieder T et al. Phospholipid analogue hexadecylphosphocholine inhibits proliferation and phosphatidylcholine biosynthesis of human epidermal keratinocytes in vitro. J Invest Dermatol 1994; 102: 490-4.
13. Geilen CC, Wieder T, Haase A et al. Uptake, subcellular distribution and metabolism of the phospholipid analogue hexadecylphosphocholine in MDCK cells. Biochim Biophys Acta 1994; 1211: 14-22.
14. Breiser A, Kim D-J, Fleer EAM et al. Distribution and metabolism of hexadecylphosphocholine in mice. Lipids 1987; 22: 925-6.
15. Dummer R, Röger J, Vogt T et al. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res 1992; 34: 160-9.
16. 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 1991; 115: 1427-36.
17. 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 1991; 67: 403-10.
18. Bonkamp P, Petrussevska RT, Breitkreutz D et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
19. Ryle CM, Breitkreutz D, Stark H-J et al. Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HaCaT and in ras-transfected tumorigenic clones. Differentiation 1989; 40: 42-54.
20. Tilgen W, Boukamp P, Breitkreutz D et al. Preservation of morphological, functional and kryotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas. Cancer Res 1983; 43: 5995-6001.
21. Steinberg ML, Defendi V. Altered pattern of growth and differentiation in human keratinocytes infected with Simian virus 40. Proc Natl Acad Sci USA 1979; 76: 801-5.
22. Bernard BA, Robinson SM, Semat A et al. Reexpression of fetal characters in Simian virus 40-transformed human keratinocytes. Cancer Res 1985; 45: 1707-16.
23. Eisinger M, Lee JS, Hefton JM et al. Human epidermal cell cultures: growth and differentiation in the absence of dermal components or medium supplements. Proc Natl Acad Sci USA 1979; 76: 5340-44.
24. Geilen CC, Wieder T, Reutter W. Hexadecylphosphocholine inhibits translocation of CTP:phosphocholine cytidylyltransferase in Madin-Darby canine kidney cells. J Biol Chem 1992; 267: 6719-24.
25. Stadler R, Detmar M, Stephanek K et al. A rapid fluorometric assay for the determination of keratinocyte proliferation in vitro. J Invest Dermatol 1989; 93: 532-4.
26. Schön MP, Schön M, Klein CE et al. Carcinoma-associated 38-kD membrane glycoprotein MH 99/KS1/4 is related to proliferation and age of transformed epithelial cell lines. J Invest Dermatol 1994; 102: 987-91.
27. Unger C, Eibl H, Breiser A et al. Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial. Onkologie 1988; 11: 295-6.
28. Muschiol C, Berger MR, Schuler B et al. Alkylphosphocholines: toxicity and anticancer properties. Lipids 1988; 22: 930-4.
29. Hilgard P, Stekar J, Voegeli R et al. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Eur J Clin Oncol 1988; 24: 1437-61.
30. Hilgard P, Harlemann JH, Voegeli R et al. The antineoplastic activity of hexadecylphosphocholine (HePC) is associated with tumor cell differentiation. Proc Am Assoc Cancer Res 1989; 30: 2310.
31. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
32. Vance DE. Phosphatidylcholine metabolism: masochistic enzymology, metabolic regulation, and lipoprotein assembly. Biochem Cell Biol 1990; 68: 1151-65.
33. Zheng B, Oishi K, Shoji M et al. Inhibition of protein kinase C (sodium plus potassium)-activated adenosine triphosphatase and sodium pump by synthetic phospholipid analogues. Cancer Res 1990; 50: 3025-31.
34. Überall F, Oberhuber H, Maly K et al. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 1991; 51: 807-12.
35. Geilen CC, Haase R, Buchner K et al. The phospholipid analogue, hexadecylphosphocholine, inhibits protein kinase C in vitro and antagonizes phorbol ester stimulated cell proliferation. Eur J Cancer 1991; 27: 1650-3.
36. Martin P, Hopkinson-Wooley J, McCluskey J. Growth factors and cutaneous wound repair. Prog Growth Factor Res 1992; 4: 25-44.
37. O'Neill C, Jordan P, Ireland G. Evidence for two distinct mechanisms of anchorage stimulation in freshly explanted and 3T3 mouse fibroblasts. Cell 1986; 44: 489-96.
38. 1-control G1/S transit specifically. J Cell Biol 1993; 122: 461-71.
39. 2 integrin subunit in mouse melanoma cells confers the ability to undergo collagen-directed adhesion, migration, and matrix-reorganization. J Invest Dermatol 1996; 106: 1175-81.